Pfizer

New York, New York 10018

1 studies enrolling now · 45 studies all time

What they study most

ALK-positive Advanced NSCLC, ALK-positive NSCLC, ALK-positive Non-small-cell Lung Cancer, ATTR-CM, Achondroplasia, Alopecia Areata, Anticoagulants, Arthritis Rheumatoid, Arthritis, Rheumatoid, Atopic Dermatitis, Atrial Fibrillation, Breast Neoplasms

Studies at this site

• A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring — Recruiting now
• A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market — Completed
• Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data — Completed
• A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults. — Completed
• A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia — Running, not enrolling
• Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants — Running, not enrolling
• A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings — Completed
• Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US — Running, not enrolling
• A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment — Running, not enrolling
• A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease — Running, not enrolling
• Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy — Completed
• A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza — Running, not enrolling
• Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania — Running, not enrolling
• Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey — Completed
• Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer. — Completed
• Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy — Running, not enrolling
• To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. — Completed
• Description of Relugolix Use in Patients With Prostate Cancer Within the VHA — Completed
• A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19 — Running, not enrolling
• Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine — Stopped early
• A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV — Completed
• A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users. — Completed
• A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis — Completed
• A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US — Completed
• A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies — Completed
• A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States. — Completed
• A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis — Completed
• A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings — Completed
• Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine — Completed
• To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma — Completed
• A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF). — Completed
• Treatment Patterns Among Patients With Venous Thromboembolism in the United States — Completed
• A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma — Completed
• This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times. — Completed
• A Study to Learn About Recifercept in Patients With Achondroplasia — Completed
• A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis — Completed
• Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy — Completed
• A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma — Completed
• Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy. — Completed
• Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) — Completed
• A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis — Completed
• Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX — Completed
• A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A Day — Completed
• Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare — Completed
• Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics — Completed